Skip to content

Utah Medical Products UTMD Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period at other companies

Baxter International logo
Baxter InternationalBAX
4.1M+295%
Intuitive Surgical logo
Intuitive SurgicalISRG

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod.

The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's share-based compensation arrangement by share-based payment award, options, expirations in period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's share-based compensation arrangement by share-based payment award, options, expirations in period?
Utah Medical Products (UTMD) reported share-based compensation arrangement by share-based payment award, options, expirations in period of 700 in Q4 2025.
How has Utah Medical Products's share-based compensation arrangement by share-based payment award, options, expirations in period changed year-over-year?
Utah Medical Products's share-based compensation arrangement by share-based payment award, options, expirations in period decreased by 76.7% year-over-year, from 3K to 700.
What does share-based compensation arrangement by share-based payment award, options, expirations in period mean?
The total value or volume of stock options that have expired during the reporting period without being exercised. This metric provides insight into the historical utilization of equity incentive plans and the potential reversal of previously recognized compensation expenses. It helps investors understand the lifecycle of employee equity awards.